Exponent, Inc. (NASDAQ:EXPO) is included among the 15 Overlooked Dividend Stocks to Buy Right Now. On November 2, Truist lowered its price target for Exponent, Inc. (NASDAQ:EXPO) from $100 to $90 ...
Conestoga Capital Advisors, an independent investment management company based in Pennsylvania, recently disclosed a sale of roughly $24.6 million worth of Exponent stock.
Scientific consulting firm Exponent (NASDAQ:EXPO) will be announcing earnings results this Thursday afternoon. Here’s what to look for. Exponent beat analysts’ revenue expectations by 1.5% last ...
Q3 2025 Earnings Call Transcript October 30, 2025 Exponent, Inc. beats earnings expectations. Reported EPS is $0.55, expectations were $0.5. Operator: Good day, and welcome to the Exponent, Inc. Third ...
Exponent missed on fourth-quarter earnings and warned revenue would be flat to down slightly in 2024. The consulting firm has seen customers delay, slowing revenue. Exponent is upping its dividend and ...
Exponent is returning to a 13-week fiscal fourth quarter in 2025, which poses a headwind for comparisons since Q4 of fiscal 2024 benefited from a 14th week. For the fourth quarter of fiscal 2025 as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback